Magnetocardiographic findings and follow-up in an asymptomatic Brugada patient. Effects of Flecainide and of exercise tests

D. Brisinda, G. Bottelli, C. Napolitano, S. G. Priori, R. Fenici

Research output: Contribution to journalArticle

Abstract

The Brugada syndrome (BS) is a genetically transmitted arrhythmogenic disease, which requires risk stratification, especially in asymptomatic subjects. Recent studies have shown that magnetocardiographic mapping (MCG) at rest can detect abnormal current distribution located in the RVOT. Here we describe an asymptomatic 28 years old BS patient, studied with 12-lead ECG and 36-channel MCG for three times at rest, under effort and during flecainide (Flec) tests, along a four years follow-up. He had a type 2 BS ECG at rest, but normal physical examination, echocardiogram and MRI. Molecular screening of the SCNC5A open reading frame revealed a de novo missense mutation in the DII-DIII linker, confirming the diagnosis of BS. For MCG assessment of ventricular repolarization (VR), magnetic field (MF) dynamics and MF gradient orientation, were computed during the ST interval and at the T wave peak. Current density reconstruction (CDR) and the strength of the equivalent current dipole (ECD) were calculated during the JT interval, to evidence potentially arrhythmogenic current flowing. In spite of Flec-induced ECG abnormality (typical type-1 ST elevation in V1-V3), MCG didn't show clear-cut variation of VR parameters, which didn't differ from those of healthy controls, at rest and under effort. After Flec, CDR, calculated every 10 ms from the J point, evidenced a change in the direction of the strongest current toward the right ventricular outflow tract, without a significant increase of the JT ECD strength. During the follow-up the patient was asymptomatic and no arrhythmia occurred. Further work is deserved to establish the predictive value of MCG for non-invasive risk stratification in asymptomatic BS patients with abnormal Flec test.

Original languageEnglish
Pages (from-to)459-462
Number of pages4
JournalInternational Congress Series
Volume1300
DOIs
Publication statusPublished - Jun 2007

Fingerprint

Flecainide
Brugada Syndrome
Exercise Test
Electrocardiography
Magnetic Fields
Missense Mutation
Open Reading Frames
Physical Examination
Cardiac Arrhythmias

Keywords

  • Arrhythmogenic risk
  • Brugada syndrome
  • Genetic analysis
  • Ventricular repolarization

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Magnetocardiographic findings and follow-up in an asymptomatic Brugada patient. Effects of Flecainide and of exercise tests. / Brisinda, D.; Bottelli, G.; Napolitano, C.; Priori, S. G.; Fenici, R.

In: International Congress Series, Vol. 1300, 06.2007, p. 459-462.

Research output: Contribution to journalArticle

@article{2f604ad7eb5347aa94c9138373e46b0e,
title = "Magnetocardiographic findings and follow-up in an asymptomatic Brugada patient. Effects of Flecainide and of exercise tests",
abstract = "The Brugada syndrome (BS) is a genetically transmitted arrhythmogenic disease, which requires risk stratification, especially in asymptomatic subjects. Recent studies have shown that magnetocardiographic mapping (MCG) at rest can detect abnormal current distribution located in the RVOT. Here we describe an asymptomatic 28 years old BS patient, studied with 12-lead ECG and 36-channel MCG for three times at rest, under effort and during flecainide (Flec) tests, along a four years follow-up. He had a type 2 BS ECG at rest, but normal physical examination, echocardiogram and MRI. Molecular screening of the SCNC5A open reading frame revealed a de novo missense mutation in the DII-DIII linker, confirming the diagnosis of BS. For MCG assessment of ventricular repolarization (VR), magnetic field (MF) dynamics and MF gradient orientation, were computed during the ST interval and at the T wave peak. Current density reconstruction (CDR) and the strength of the equivalent current dipole (ECD) were calculated during the JT interval, to evidence potentially arrhythmogenic current flowing. In spite of Flec-induced ECG abnormality (typical type-1 ST elevation in V1-V3), MCG didn't show clear-cut variation of VR parameters, which didn't differ from those of healthy controls, at rest and under effort. After Flec, CDR, calculated every 10 ms from the J point, evidenced a change in the direction of the strongest current toward the right ventricular outflow tract, without a significant increase of the JT ECD strength. During the follow-up the patient was asymptomatic and no arrhythmia occurred. Further work is deserved to establish the predictive value of MCG for non-invasive risk stratification in asymptomatic BS patients with abnormal Flec test.",
keywords = "Arrhythmogenic risk, Brugada syndrome, Genetic analysis, Ventricular repolarization",
author = "D. Brisinda and G. Bottelli and C. Napolitano and Priori, {S. G.} and R. Fenici",
year = "2007",
month = "6",
doi = "10.1016/j.ics.2006.12.079",
language = "English",
volume = "1300",
pages = "459--462",
journal = "International Congress Series",
issn = "0531-5131",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Magnetocardiographic findings and follow-up in an asymptomatic Brugada patient. Effects of Flecainide and of exercise tests

AU - Brisinda, D.

AU - Bottelli, G.

AU - Napolitano, C.

AU - Priori, S. G.

AU - Fenici, R.

PY - 2007/6

Y1 - 2007/6

N2 - The Brugada syndrome (BS) is a genetically transmitted arrhythmogenic disease, which requires risk stratification, especially in asymptomatic subjects. Recent studies have shown that magnetocardiographic mapping (MCG) at rest can detect abnormal current distribution located in the RVOT. Here we describe an asymptomatic 28 years old BS patient, studied with 12-lead ECG and 36-channel MCG for three times at rest, under effort and during flecainide (Flec) tests, along a four years follow-up. He had a type 2 BS ECG at rest, but normal physical examination, echocardiogram and MRI. Molecular screening of the SCNC5A open reading frame revealed a de novo missense mutation in the DII-DIII linker, confirming the diagnosis of BS. For MCG assessment of ventricular repolarization (VR), magnetic field (MF) dynamics and MF gradient orientation, were computed during the ST interval and at the T wave peak. Current density reconstruction (CDR) and the strength of the equivalent current dipole (ECD) were calculated during the JT interval, to evidence potentially arrhythmogenic current flowing. In spite of Flec-induced ECG abnormality (typical type-1 ST elevation in V1-V3), MCG didn't show clear-cut variation of VR parameters, which didn't differ from those of healthy controls, at rest and under effort. After Flec, CDR, calculated every 10 ms from the J point, evidenced a change in the direction of the strongest current toward the right ventricular outflow tract, without a significant increase of the JT ECD strength. During the follow-up the patient was asymptomatic and no arrhythmia occurred. Further work is deserved to establish the predictive value of MCG for non-invasive risk stratification in asymptomatic BS patients with abnormal Flec test.

AB - The Brugada syndrome (BS) is a genetically transmitted arrhythmogenic disease, which requires risk stratification, especially in asymptomatic subjects. Recent studies have shown that magnetocardiographic mapping (MCG) at rest can detect abnormal current distribution located in the RVOT. Here we describe an asymptomatic 28 years old BS patient, studied with 12-lead ECG and 36-channel MCG for three times at rest, under effort and during flecainide (Flec) tests, along a four years follow-up. He had a type 2 BS ECG at rest, but normal physical examination, echocardiogram and MRI. Molecular screening of the SCNC5A open reading frame revealed a de novo missense mutation in the DII-DIII linker, confirming the diagnosis of BS. For MCG assessment of ventricular repolarization (VR), magnetic field (MF) dynamics and MF gradient orientation, were computed during the ST interval and at the T wave peak. Current density reconstruction (CDR) and the strength of the equivalent current dipole (ECD) were calculated during the JT interval, to evidence potentially arrhythmogenic current flowing. In spite of Flec-induced ECG abnormality (typical type-1 ST elevation in V1-V3), MCG didn't show clear-cut variation of VR parameters, which didn't differ from those of healthy controls, at rest and under effort. After Flec, CDR, calculated every 10 ms from the J point, evidenced a change in the direction of the strongest current toward the right ventricular outflow tract, without a significant increase of the JT ECD strength. During the follow-up the patient was asymptomatic and no arrhythmia occurred. Further work is deserved to establish the predictive value of MCG for non-invasive risk stratification in asymptomatic BS patients with abnormal Flec test.

KW - Arrhythmogenic risk

KW - Brugada syndrome

KW - Genetic analysis

KW - Ventricular repolarization

UR - http://www.scopus.com/inward/record.url?scp=34250005702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250005702&partnerID=8YFLogxK

U2 - 10.1016/j.ics.2006.12.079

DO - 10.1016/j.ics.2006.12.079

M3 - Article

AN - SCOPUS:34250005702

VL - 1300

SP - 459

EP - 462

JO - International Congress Series

JF - International Congress Series

SN - 0531-5131

ER -